Recent advances on nanoparticle-based therapies for cardiovascular diseases
Author:
Funder
Department of Health Research, India
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference122 articles.
1. NCDs: a challenge to sustainable human development;Clark;Lancet,2013
2. Cardiovascular diseases (CVDs),2021
3. The use of nanotechnology in cardiovascular disease;Chandarana;Appl Nanosci,2018
4. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2;Zhao;Cell,2007
5. Heart regeneration;Laflamme;Nature,2011
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanomedicine: A great boon for cardiac regenerative medicine;European Journal of Pharmacology;2024-11
2. Biosynthesis of gold nanoparticles by the extremophile bacterium Deinococcus radiodurans and an evaluation of its application in drug delivery;Process Biochemistry;2024-10
3. Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders;Current Gene Therapy;2024-10
4. Insights into the prospects of nanobiomaterials in the treatment of cardiac arrhythmia;Journal of Nanobiotechnology;2024-08-30
5. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3